Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa [letter]

L. Lynen; K. Fransen; J. van Griensven; R. Colebunders

doi:10.1016/S1473-3099(12)70279-7

Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa [letter]

L. Lynen, K. Fransen, J. van Griensven, R. Colebunders

HIV and Tuberculosis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Lancet Infectious Diseases
Volume	12
Issue number	12
Pages (from-to)	911
Number of pages	1
ISSN	1473-3099
DOIs	https://doi.org/10.1016/S1473-3099(12)70279-7
Publication status	Published - 2012

Keywords

Viral diseases
HIV-1
AIDS
HAART
Antiretrovirals
Drug resistance
Testing
Viral load
Second-line drugs
Availability
Africa-General

Access to Document

10.1016/S1473-3099(12)70279-7

http://lib.itg.be/pdf/itg/2012/2012lanc0911.pdf

Cite this

@article{abfddaae467947668d6916b4078e128e,

title = "Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa [letter]",

keywords = "Viral diseases, HIV-1, AIDS, HAART, Antiretrovirals, Drug resistance, Testing, Viral load, Second-line drugs, Availability, Africa-General",

author = "L. Lynen and K. Fransen and {van Griensven}, J. and R. Colebunders",

note = "NPP; ITG-C1A; ITG-C2A; ITG-C3A; ITG-CLA; DCS; U-CTU; U-INFDIS; U-ARLAB; U-HIVCLI; JIF; DOI; PDF; DSPACE",

year = "2012",

doi = "10.1016/S1473-3099(12)70279-7",

language = "English",

volume = "12",

pages = "911",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa [letter]

AU - Lynen, L.

AU - Fransen, K.

AU - van Griensven, J.

AU - Colebunders, R.

N1 - NPP; ITG-C1A; ITG-C2A; ITG-C3A; ITG-CLA; DCS; U-CTU; U-INFDIS; U-ARLAB; U-HIVCLI; JIF; DOI; PDF; DSPACE

PY - 2012

Y1 - 2012

KW - Viral diseases

KW - HIV-1

KW - AIDS

KW - HAART

KW - Antiretrovirals

KW - Drug resistance

KW - Testing

KW - Viral load

KW - Second-line drugs

KW - Availability

KW - Africa-General

U2 - 10.1016/S1473-3099(12)70279-7

DO - 10.1016/S1473-3099(12)70279-7

M3 - Letter

C2 - 23174380

SN - 1473-3099

VL - 12

SP - 911

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 12

ER -